CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 92 filers reported holding CUE BIOPHARMA INC in Q2 2021. The put-call ratio across all filers is 2.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,200 | -49.6% | 4,000 | -20.0% | 0.01% | -44.4% |
| Q2 2023 | $18,250 | +2.2% | 5,000 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $17,850 | -63.2% | 5,000 | -70.6% | 0.01% | -67.9% |
| Q4 2022 | $48,450 | +27.5% | 17,000 | 0.0% | 0.03% | +27.3% |
| Q3 2022 | $38,000 | +26.7% | 17,000 | +41.7% | 0.02% | +15.8% |
| Q2 2022 | $30,000 | +50.0% | 12,000 | +200.0% | 0.02% | +90.0% |
| Q1 2022 | $20,000 | -55.6% | 4,000 | 0.0% | 0.01% | -52.4% |
| Q4 2021 | $45,000 | -22.4% | 4,000 | 0.0% | 0.02% | -41.7% |
| Q3 2021 | $58,000 | +23.4% | 4,000 | 0.0% | 0.04% | +24.1% |
| Q2 2021 | $47,000 | -4.1% | 4,000 | 0.0% | 0.03% | -19.4% |
| Q1 2021 | $49,000 | -2.0% | 4,000 | 0.0% | 0.04% | -12.2% |
| Q4 2020 | $50,000 | -16.7% | 4,000 | 0.0% | 0.04% | -30.5% |
| Q3 2020 | $60,000 | – | 4,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 829,042 | $9,376,000 | 5.61% |
| P.A.W. CAPITAL CORP | 120,000 | $1,357,000 | 1.24% |
| Nantahala Capital Management | 2,539,700 | $28,724,000 | 1.01% |
| Slate Path Capital LP | 1,483,619 | $16,780,000 | 0.88% |
| SANDERS MORRIS HARRIS LLC | 359,113 | $4,416,000 | 0.76% |
| APOGEM CAPITAL LLC | 62,295 | $705,000 | 0.46% |
| Robertson Stephens Wealth Management, LLC | 478,500 | $5,411,000 | 0.46% |
| Bleichroeder LP | 200,000 | $2,262,000 | 0.35% |
| ADVISORY RESEARCH INC | 257,225 | $2,909,000 | 0.23% |
| Granite Point Capital Management, L.P. | 110,000 | $1,244,000 | 0.21% |